TMEM106B has been identified as a risk factor for ﻿frontotemporal lobar degeneration ﻿with progranulin mutations and elevated mRNA and protein levels of TMEM106B are associated with increased risk for frontotemporal lobar degeneration. This evidence concerns the gene TMEM106B and frontotemporal dementia.